Michael Scolaro

Michael Scolaro

Nov 10, 2017

Group 6 Copy 245
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Fancy footwork: How different are the feet of zoo and wild giraffe?

Cooperative training helps zookeepers care for zoo animals. For giraffe, much of this training focuses on...

Mapping Addiction

Addiction and drug dependence are preventable and treatable diseases. Understanding the neurophysiological...

How does taking Ritalin affect depersonalization-derealization disorder patients?

We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

Backer Badge Funded